JUN 24, 2019 9:43 AM PDT

'Sugar-coating' proteins to treat pancreatitis?

WRITTEN BY: Nouran Amin

A powerful biomarker created by complex sugar molecules, called CA19-9, may be a target for the treatment of pancreatitis. Pancreatitis is an inflammatory disease of the pancreas that results in 275,000 annual hospitalizations in the United States. Individuals with hereditary pancreatitis are at risk in developing pancreatic cancer.

Learn more about pancreatitis:

"Pancreatitis is required for developing pancreatic cancer, and we might be able to prevent that transition in patients with pancreatitis by targeting CA19-9," says Dannielle Engle, a former Cold Spring Harbor Laboratory (CSHL) Cancer Center postdoctoral fellow and appointed Assistant Professor at Salk Institute "By targeting CA19-9 with antibodies in animal models, we were able to reduce the severity of pancreatitis and even prevent it from occurring."

Credit, Cold Spring Harbor Laboratory (CSHL): Pancreatic lineage immunofluorescence (IF) of the whole body, R;F CA19-9 mouse model.

Findings were published in the journal Science and describes that mice who produced CA19-9--a complex sugar structure that coats many proteins but had not been previously ascribed with any particular function--surprisingly developed severe pancreatitis. CA19-9 was also shown to dramatically result in the the growth of pancreatic tumors. Overall, the findings conclude that CA19-9 may be an attractive therapeutic target for pancreatitis.

"This is one of those unique opportunities where prophylactic intervention of pancreatitis may lead to prevention of pancreatic cancer in at-risk patients," Engle said.

An application was filed by CSHL in current pending status for the use of CA19-9 antibodies for treating and preventing pancreatitis.

Source: Cold Spring Harbor Laboratory (CSHL)

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 06, 2020
Drug Discovery & Development
JAN 06, 2020
Designing Drugs To Fight off C. Diff Infections
A study published by PNAS explains breakthrough research around designing drugs that target C. diff bacterial infections that result in 15,000 deaths in th...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
JAN 22, 2020
Cannabis Sciences
JAN 22, 2020
Antibiotic Properties Found in Cannabis Compound
The World Health Organization has identified antibiotic resistance, when bacteria no longer respond to antibiotics, as one of the biggest threats to global...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
FEB 08, 2020
Drug Discovery & Development
FEB 08, 2020
Drug Targets Brain-Eating Amoebas
Brain-eating amoebas lead to high rates of mortality as a result of encephalitis. In fact, more than 95% of people who develop the infection will die. Unfo...
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
Treating stroke with low dose of clot-busting drug
A study concludes that a low-dose of the clot-busting drug—tenecteplase—may be beneficial for eligible stroke patients that do not need an inte...
Loading Comments...